OS Therapies (OSTX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

OS Therapies

NYSE: OSTX · Real-Time Price · USD
2.31
0.11 (5.00%)
At close: Sep 11, 2025, 1:14 PM

OS Therapies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-8.88M -7.79M -6.25M -7.42M
Depreciation & Amortization
2.78K 4.22K 805.00 805.00
Stock-Based Compensation
268.3K n/a n/a n/a
Other Working Capital
923.69K 669.65K 730.9K -281.81K
Other Non-Cash Items
1.46M 2.76M 1.51M 2.44M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-129.64K 2.02M 947.33K 574.67K
Operating Cash Flow
-7.28M -3.01M -3.79M -4.4M
Capital Expenditures
n/a n/a n/a -11.93K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 1.15K 230.88K 212.41K
Investing Cash Flow
n/a 1.15K 230.88K 200.47K
Debt Repayment
1.5M 3.16M 3.82M 2.95M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-31.25M n/a n/a n/a
Other Financial Acitivies
31.25M -284.18K -172.02K 100K
Financial Cash Flow
12.78M 2.87M 3.65M 3.05M
Net Cash Flow
5.49M -132.5K 90.69K -1.15M
Free Cash Flow
-7.28M -3.01M -3.79M -4.41M